Fresenius building renal genomic registry to inform precision care for kidney disease

by on

Globally, Fresenius actively manages 350,000 patients with end-stage renal disease and provides nearly 52 million dialysis treatments annually in about 50 different countries.

Globally, Fresenius actively manages 350,000 patients with end-stage renal disease and provides nearly 52 million dialysis treatments annually in about 50 different countries.

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: